Last $0.0010 USD
Change Today -0.0001 / -9.09%
Volume 9.6M
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harry Fisch

Member of Board of Scientific Advisor, IntelliCell BioSciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Harry Fisch has been Member of Board of Scientific Advisor at IntelliCell BioSciences, Inc. since December 10, 2012. Dr. Fisch heads up the new Urology Department at IntelliCell. He is a board-certified urologist and microsurgeon. He is Clinical Professor of Urology and Reproductive Medicine at Weill-Cornell Medical College/New York Presbyterian Hospital. He is one of the nation's leaders in the diagnosis and treatment of Men's health issues as well as sexuality ...

Read Full Background

Corporate Headquarters*

460 Park Avenue
New York, New York 10022

United States

Phone: 212-249-3050
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVFC:US $0.00 USD -0.0001

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Aastrom Biosciences, Inc.
$358.3K
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$406.6K
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Mark Weinreb M.S.Chairman, Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer
BioRestorative Therapies, Inc.
$360.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTELLICELL BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.